Teladoc Health
TDOC
7.45
-0.34
-4.36%
Teladoc Health
US · TDOC
#3241 by market cap
Listed 2015
7.45
-0.34
-4.36%
Periodic snapshot; not a real-time feed.
· 2026-11-20 19:44
✦ Quant Ownership Signal how this is computed
Accumulating
- The number of reporting institutions decreased by 13 in the most recent period (2026/Q3).
- Total institutional ownership rose 6.1 percentage points.
Ownership vs. money flow
AlignedInstitutions added shares last reporting period, and the stock has seen net inflows in main-fund flow over the last 20 trading sessions - the two line up.
Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.
Institutional ownership
- Held by institutions
- 90.85% +6.14pp
- Institutions
- 403 -13
- As of
- 2026/Q3 vs. prior period
Holder types
Mutual Fund65.18%
Hedge Fund17.84%
Public Company3.84%
Private Company2.05%
VC/PE Fund1.10%
Individual/Insider0.67%
Government Pension Fund0.47%
Insurance Company0.26%
Other8.53%
Top holders as of 2026-09-30
BlackRock
10.28% · 18.73M sh
Vanguard Portfolio Management, LLC
7.83% · 14.27M sh
American Century Investment Management
5.22% · 9.51M sh
Dimensional Fund Advisors
4.99% · 9.10M sh
Point72 Asset Management, L.P.
4.52% · 8.24M sh
Voss Capital, LP
4.41% · 8.05M sh
Renaissance Technologies Corp.
4.39% · 8.00M sh
Vanguard Capital Management, LLC
4.38% · 7.98M sh
State Street Global Advisors
2.71% · 4.94M sh
Pacific Investment Management Company LLC
2.56% · 4.67M sh
Bar length is relative to the largest holder shown here, not to 100% of the company.
Insiders
50 filings tracked · 13 buys · 34 sells
| Name | Role | Stake |
|---|---|---|
| Charles Divita | Chief Executive Officer | 0.26% |
| David Snow | Former Independent Non-Executive Director | 0.09% |
| Mala Murthy | Former Chief Financial Officer | 0.08% |
| Adam Vandervoort | Former Chief Legal Officer | 0.06% |
| Kelly Bliss | President of U.S. Group Health | 0.05% |
| Catherine Jacobson | Independent Director | 0.04% |
| David Shedlarz | Independent Director | 0.03% |
| Sandra Fenwick | Independent Director | 0.02% |
| Carlos Nueno | President of Global Health Systems | 0.02% |
| Joseph Catapano | Chief Accounting Officer | 0.01% |
Insider transactions most recent Form 4 filings
| Date | Name | Role | Type | Shares | Price |
|---|---|---|---|---|---|
| 2026-11-05 | Carlos Nueno | President of Global Health Systems | Automatic Disposition | -29,432 | $9.20 |
| 2026-11-01 | Jonathan Dorfman | Chief Legal Officer | Initial Statement of Beneficial | 0 | -- |
| 2026-10-01 | Joseph Catapano | Chief Accounting Officer | Derivative Exercise and Sale | -655 | $5.65 |
| 2026-09-30 | Joseph Catapano | Chief Accounting Officer | Derivative Exercise and Retained | +1,428 | -- |
| 2026-09-10 | Charles Divita | Chief Executive Officer | Derivative Exercise and Sale | -17,805 | $6.10 |
| 2026-09-10 | Charles Divita | Chief Executive Officer | Intent to Sell (Form 144) | -17,805 | $6.10 |
| 2026-09-09 | Charles Divita | Chief Executive Officer | Derivative Exercise and Retained | +24,997 | -- |
| 2026-09-02 | Fernando Madeira | President of BetterHelp | Derivative Exercise and Sale | -15,251 | $6.30–6.51 |
| 2026-09-02 | Fernando Madeira | President of BetterHelp | Intent to Sell (Form 144) | -9,812 | $6.51 |
| 2026-09-01 | Charles Divita | Chief Executive Officer | Derivative Exercise and Sale | -18,327 | $6.30 |
| 2026-09-01 | Charles Divita | Chief Executive Officer | Intent to Sell (Form 144) | -18,327 | $6.30 |
| 2026-09-01 | Joseph Catapano | Chief Accounting Officer | Derivative Exercise and Sale | -274 | $6.30 |
| 2026-09-01 | Adam Vandervoort | Former Chief Legal Officer | Derivative Exercise and Sale | -7,573 | $6.30 |
| 2026-09-01 | Adam Vandervoort | Former Chief Legal Officer | Intent to Sell (Form 144) | -7,573 | $6.30 |
| 2026-09-01 | Fernando Madeira | President of BetterHelp | Intent to Sell (Form 144) | -5,439 | $6.30 |
| 2026-09-01 | Kelly Bliss | President of U.S. Group Health | Derivative Exercise and Sale | -7,357 | $6.30 |
| 2026-09-01 | Kelly Bliss | President of U.S. Group Health | Intent to Sell (Form 144) | -7,357 | $6.30 |
| 2026-09-01 | Carlos Nueno | President of Global Health Systems | Derivative Exercise and Sale | -6,200 | $6.30 |
| 2026-09-01 | Carlos Nueno | President of Global Health Systems | Intent to Sell (Form 144) | -6,200 | $6.30 |
| 2026-08-31 | Charles Divita | Chief Executive Officer | Derivative Exercise and Retained | +25,916 | -- |
Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.
Quote time 2026-11-20 19:44:00 · For reference only, not investment advice and not tailored to your situation.
Teladoc Health discussion 0 comments